National Cancer Institute
Found 864 results for your search:
Total relevant funding to Colon/Rectum for this search:
$208,406,608
Fiscal Year FY 2017
Cancer Type [Colon/Rectum]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 864 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
(1) Intestinal Organoid Models for APC LOH 5R21CA208638-02 $192,406 $192,406 GIARDINA, CHARLES UNIVERSITY OF CONNECTICUT STORRS
2
(10.) The Gut Microbiome and Responses to Neoadjuvant Chemoradiation in Rectal Cancer Patients 5R21CA205636-02 $202,275 $202,275 CHEN, GRACE UNIVERSITY OF MICHIGAN
3
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities 5U54CA143930-08 $704,474 $112,716 FARIAS-EISNER, ROBIN UNIVERSITY OF CALIFORNIA LOS ANGELES
4
(PQ1) GUCY2C hormone loss translates APC-Beta-catenin mutations into epithelial transformation 5R01CA206026-02 $356,850 $356,850 WALDMAN, SCOTT THOMAS JEFFERSON UNIVERSITY
5
(PQ10) Do microbiota alter the epigenetic landscape in human genome 5R21CA208464-02 $212,063 $212,063 STRONGIN, ALEX SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
6
(PQ3) Immune Modulation of DNA Mismatch Repair in Colorectal Cancer 5R01CA206010-02 $369,639 $369,639 CARETHERS, JOHN UNIVERSITY OF MICHIGAN
7
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity 5R01CA208756-02 $518,165 $259,083 HACOHEN, NIR BROAD INSTITUTE, INC.
8
(PQ5) Investigation of intertumoral and intratumoral heterogeneity of mitochondrial apoptotic sensitivity 5R01CA205967-02 $386,588 $386,588 LETAI, ANTHONY DANA-FARBER CANCER INST
9
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states. 1R01CA220004-01 $739,041 $739,041 GRADY, WILLIAM FRED HUTCHINSON CANCER RESEARCH CENTER
10
(PQA1)The Molecular Mechanisms Underlying Effects of Aspirin on Colorectal Cancer 5R01CA184820-04 $386,650 $386,650 DUBOIS, RAYMOND MEDICAL UNIVERSITY OF SOUTH CAROLINA
11
(PQB-4) Opposing Effects of the SASP in Cancer Progression 5R01CA184572-04 $329,925 $108,875 HERBIG, UTZ RBHS-NEW JERSEY MEDICAL SCHOOL
12
(PQB-4) Single cell analysis strategy for monitoring drug responses of tumors 5R01CA190122-04 $571,080 $571,080 TIAN, QIANG INSTITUTE FOR SYSTEMS BIOLOGY
13
(PQC-1) Driver Events In IBD-Associated Neoplastic Progression 5R01CA190040-04 $613,138 $613,138 MELTZER, STEPHEN JOHNS HOPKINS UNIVERSITY
14
(PQC1) Accelerated biological aging and colon polyp to cancer progression 5R01CA194663-03 $401,482 $401,482 GRADY, WILLIAM FRED HUTCHINSON CANCER RESEARCH CENTER
15
0021.0001 CG 425 METAVIVOR 261200800001E $319,219,481 $183,367 UNKNOWN, UNKNOWN LEIDOS BIOMEDICAL RESEARCH, INC.
16
1/2 SDSU/UCSD Cancer Center Comprehensive Partnership 5U54CA132379-08 $1,258,708 $566,419 MARTINEZ, MARIA UNIVERSITY OF CALIFORNIA SAN DIEGO
17
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership 5P20CA192973-04 $191,836 $95,918 MANNE, UPENDER UNIVERSITY OF ALABAMA AT BIRMINGHAM
18
1/2: Partnership to study racial/ethnic differences in GI cancer biology 3P20CA192994-03S1 $63,140 $25,887 LI, ELLEN STATE UNIVERSITY NEW YORK STONY BROOK
19
1/2: Partnership to study racial/ethnic differences in GI cancer biology 5P20CA192994-03 $288,919 $118,457 LI, ELLEN STATE UNIVERSITY NEW YORK STONY BROOK
20
15-Hydroxyprostaglandin Dehydrogenase, NSAIDs, Vitamin D, and Coloretcal Neoplasi 5U01CA181770-04 $507,599 $507,599 LI, LI CASE WESTERN RESERVE UNIVERSITY
21
15-LOX-1 Modulation of Colon Cancer Promotion by Linoleic Acid 5R01CA206539-02 $366,000 $366,000 SHUREIQI, IMAD UNIVERSITY OF TX MD ANDERSON CAN CTR
22
15-LOX-1 Regulation of Resolving Generation to Modulate Colon Cancer 5R01CA195686-02 $366,000 $366,000 SHUREIQI, IMAD UNIVERSITY OF TX MD ANDERSON CAN CTR
23
2/2 Partnership to Study Racial/Ethnic Differences in GI Cancer Biology 5P20CA192996-03 $154,908 $86,748 MCCOMBIE, WILLIAM COLD SPRING HARBOR LABORATORY
24
2/2 SDSU/UCSD Cancer Center Comprehensive Partnership 5U54CA132384-08 $1,192,222 $429,200 ARREDONDO, ELVA SAN DIEGO STATE UNIVERSITY
25
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership 5P20CA192976-04 $144,556 $76,615 MISHRA, MANOJ ALABAMA STATE UNIVERSITY
26
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership 5U54CA118623-12 $407,680 $114,150 TROY, ROBERTA TUSKEGEE UNIVERSITY
27
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership 5U54CA118948-12 $1,170,535 $105,348 MANNE, UPENDER UNIVERSITY OF ALABAMA AT BIRMINGHAM
28
3D Dynamic Contrast-Enhanced US for Monitoring Chemotherapy of Liver Metastasis 5R01CA195443-02 $252,908 $252,908 WILLMANN, JUERGEN STANFORD UNIVERSITY
29
A Follow-up Study for Causes of Cancer in Black Women 2U01CA164974-07 $2,195,369 $439,074 ROSENBERG, LYNN BOSTON UNIVERSITY MEDICAL CAMPUS
30
A Follow-up Study for Causes of Cancer in Black Women 5UM1CA164974-06 $639,740 $127,948 ROSENBERG, LYNN BOSTON UNIVERSITY MEDICAL CAMPUS
31
A multi-faceted approach to identifying K-Ras synthetic lethal relationships 5U01CA199252-03 $1,041,188 $520,594 HAIGIS, KEVIN BETH ISRAEL DEACONESS MEDICAL CENTER
32
A patient-centered intervention using virtual technology to reduce colorectal cancer disparities in primary care 1R01CA207689-01A1 $640,352 $640,352 RAUP-KRIEGER, JANICE UNIVERSITY OF FLORIDA
33
A PHASE I SINGLE-ARM, MULTICENTER PILOT STUDY AIMED AT VALIDATING Y-OHPDG AS A BIOMARKER AND TESTING THE EFFECTS OF POLYPHENON E ON ITS LEVELS IN PATIENTS WITH CIRRHOSIS 261201200035I $2,834,664 $2,834,664 UNKNOWN, UNKNOWN NORTHWESTERN UNIVERSITY AT CHICAGO
34
A scalable platform for target validation in GEMM models of gastrointestinal malignancies. 5R01CA195787-03 $641,206 $320,603 LOWE, SCOTT SLOAN-KETTERING INST CAN RESEARCH
35
A Stepped-Care Telehealth Approach to Treat Distress in Rural Cancer Survivors 5R21CA198237-02 $88,993 $17,799 DANHAUER, SUZANNE WAKE FOREST UNIVERSITY HEALTH SCIENCES
36
AARP prospective study of diet and cancer ZIA CP010196-03152 $703,174 $70,317 Sinha, Rashmi DCEG (NCI)
37
Abramson Cancer Center Support Grant 3P30CA016520-41S1 $125,000 $5,000 DANG, CHI UNIVERSITY OF PENNSYLVANIA
38
Abramson Cancer Center Support Grant 3P30CA016520-41S2 $62,491 $2,500 VONDERHEIDE, ROBERT UNIVERSITY OF PENNSYLVANIA
39
Abramson Cancer Center Support Grant 5P30CA016520-41 $7,810,244 $312,410 VONDERHEIDE, ROBERT UNIVERSITY OF PENNSYLVANIA
40
Accelerating Transdisciplinary Epidemiology of Colorectal Cancer 5R35CA197735-03 $869,969 $869,969 OGINO, SHUJI DANA-FARBER CANCER INST
41
Activatable molecular cancer imaging probe ZIA BC 011512 $256,560 $51,312 Kobayashi, Hisataka CCR (NCI)
42
Adaptive Intervention to Maximize Colorectal Screening in Safety Net Populations 5R01CA188898-02 $621,534 $621,534 GREINER, K UNIVERSITY OF KANSAS MEDICAL CENTER
43
Adding patient and provider viewpoints to rectal cancer practice variation data 5K07CA197067-03 $142,021 $142,021 CHARLTON, MARY UNIVERSITY OF IOWA
44
Adoptive Cell Transfer Immunotherapy of Cancer ZIA BC 010984 $1,629,581 $162,958 Rosenberg, Steven CCR (NCI)
45
Advancing Virtual Colonoscopy for Early Cancer Screening 5R01CA206171-02 $439,539 $439,539 LIANG, JEROME STATE UNIVERSITY NEW YORK STONY BROOK
46
Age and Diet: Major interacting factors that drive sporadic intestinal cancer 5R01CA174432-05 $660,173 $660,173 AUGENLICHT, LEONARD ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
47
Alliance for Clinical Trials in Oncology Operations Center 3U10CA180821-04S1 $2,088,480 $104,424 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
48
Alliance for Clinical Trials in Oncology Operations Center 5U10CA180821-04 $11,145,123 $557,256 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
49
Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment 1R01CA208343-01A1 $425,312 $425,312 EVERS, BERNARD UNIVERSITY OF KENTUCKY
50
Aminooxyacetic Acid Prodrugs for Colon Cancer Therapy 1R41CA213463-01 $300,000 $300,000 SZABO, CSABA CBS THERAPEUTICS, INC.
Total relevant funding to Colon/Rectum for this search: $208,406,608
Showing 1 - 50 of 864 results
Go to top